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Macrophage migrationThe Toll-like receptors (TLRs) play a pivotal role in innate immunity for the detection of highly conserved,
pathogen-expressed molecules. Previously, we demonstrated that lipopolysaccharide (LPS, TLR4 ligand)-
increased macrophage motility required the participation of Src and FAK, which was inducible nitric oxide
synthase (iNOS)-dependent. To investigate whether this iNOS/Src/FAK pathway is a general mechanism for
macrophages tomobilize in response to engagement of TLRs other than TLR4, peptidoglycan (PGN, TLR2 ligand),
polyinosinic–polycytidylic acid (polyI:C, TLR3 ligand) and CpG-oligodeoxynucleotides (CpG, TLR9 ligand) were
used to treat macrophages in this study. Like LPS stimulation, simultaneous increase of cell motility and Src (but
not Fgr, Hck, and Lyn) was detected in RAW264.7, peritoneal macrophages, and bone marrow-derived
macrophages exposed to PGN, polyI:C and CpG. Attenuation of Src suppressed PGN-, polyI:C-, and CpG-elicited
movement and the level of FAK Pi-Tyr861, which could be reversed by the reintroduction of siRNA-resistant Src.
Besides, knockdown of FAK reduced the mobility of macrophages stimulated with anyone of these TLR ligands.
Remarkably, PGN-, polyI:C-, and CpG-induced Src expression, FAK Pi-Tyr861, and cell mobility were inhibited in
macrophages devoid of iNOS, indicating the importance of iNOS. These ﬁndings corroborate that iNOS/Src/FAK
axis occupies a central role in macrophage locomotion in response to engagement of TLRs.MDMs, bone marrow-derived
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Macrophages are critical players in innate immunity induced by
invaded microorganisms or injured tissues. This is via the interaction
between the conserved structures called pathogen-associated molec-
ular patterns (PAMPs) in microorganisms or damage-associated
molecular patterns in the released endogenous molecules from the
damaged cells and the pattern-recognition receptors, such as Toll-like
receptors (TLRs) in macrophages [1,2]. TLRs contain N-terminal
extracellular leucine-rich repeats that mediate the recognition of
speciﬁc pathogen components, a membrane-spanning domain that
determines the cellular localization, and a C-terminal intracellular
region similar to that of the IL-1 receptor known as the Toll/IL-1
receptor (TIR) domain, which is essential for downstream signaling
[3]. There are 10 TLRs that have been identiﬁed in humans and 12 in
137M.-C. Maa et al. / Biochimica et Biophysica Acta 1813 (2011) 136–147mice [1]. Certain TLRs (i.e. TLR1, 2, 4, 5, 6 and 11) are found on the cell
surface, while others (i.e. TLR3, 7, 8 and 9) are detected almost
exclusively in intracellular compartments such as endosomes [1,4].
TLR2 recognizes peptidoglycan (PGN), a major bacterial cell wall
component. TLR4 acts as a signaling receptor for lipopolysaccharide
(LPS), an outermembrane component of Gram-negative bacteria [5,6].
As TLR3 senses viral double-stranded RNA [7], TLR9 detects the
unmethylated CpG-oligodeoxynucleotides (CpG) that are frequently
found in bacteria, but not in vertebrate DNA [8]. Subsequent to
recognition of a PAMP, TLR recruits a combination of TIR-containing
adaptors, including MyD88, TIRAP/Mal, TRAM and TRIF. It is well
documented that TLR9 utilizesMyD88, TLR3 needs TRIF, TLR2 requires
MyD88 and TIRAP, and TLR4 uses all the four aforementioned adaptors
[3]. Through individually preferential adaptors, engagement of TLRs
triggers downstream signaling pathways to activate NF-κB or MAPFig. 1. The involvement of Src family kinase(s) in PGN-, polyI:C-, and CpG-stimulated macro
(10 μM) for 1 h, and then cells were stimulated without or with (A) PGN (5 μg/ml), (B) poly
stimulated with or without (A) PGN (5 μg/ml), (B) polyI:C ((I:C)n; 20 μg/ml) and (C) CpG
modiﬁed Boyden chamber as described under “Materials and methods.” ***pb0.001; #
demonstrated.kinase and generate proinﬂammatory cytokines required for host
defensive strategies [1,4,9].
As a nonreceptor tyrosine kinase, Src is the prototype of a family of
highly conserved proteins (Fyn, Yes, Fgr, Hck, Lck, Lyn, Blk, and Yrk),
which have been implicated in diverse signaling pathways and
various cellular processes [10]. Though Lyn, Fgr and Hck are the
predominant Src family kinases (SFKs) in macrophages [11,12], their
expression is unaltered in response to LPS. By contrast, Src is barely
detectable in resting macrophages, but can be greatly induced by LPS
[13,14]. Considering the importance of cyclooxygenase-2 (COX-2) and
inducible nitric oxide synthase (iNOS), the two inducible enzymes in
infection and inﬂammation, the signiﬁcance of Src in macrophage
physiology is anticipated and ready to be disclosed.
Focal adhesion kinase (FAK) is an intracellular tyrosine kinase
localized predominantly within focal adhesion [15,16] and participatesphage migration. RAW264.7 macrophages (RAW; left) pretreated without or with PP2
I:C ((I:C)n, 20 μg/ml) and (C) nCpG or CpG (0.3 μg/ml) for 48 h. Rat PEMs (right) were
or nCpG (0.3 μg/ml) for 48 h. The motility of each group was determined by using a
##pb0.001. Similar results were repeated three times and the representative was
Fig. 2. Increased Src expression and motility in BMDMs exposed to LPS, PGN, polyI:C,
and CpG. BMDMs were stimulated without or with LPS (100 ng/ml), PGN (5 μg/ml),
polyI:C ((I:C)n; 20 μg/ml) and CpG (0.3 μg/ml) for 48 h. Equal amounts of lysates
(100 μg) from each sample were resolved by SDS-PAGE and probed with antibodies as
indicated. The motility of each group was determined as mentioned in Fig. 1. Similar
results were repeated three times and the representative was demonstrated.
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survival, cell adhesionandmigration [17,18]. Deﬁciency of FAK results in
embryonic lethality, characterized by impaired ﬁbroblast migration
[19–21]. Upon integrin stimulation, FAK becomes activated and
autophosphorylated at Tyr397 that confers the binding site for Src.
This facilitates Src-mediated FAK phosphorylation on several tyrosine
residues including Tyr861 [22,23], whose phosphorylation promotes
FAK Pi-Tyr397 [24]. It is noteworthy that FAK is initially thought to be
absent or expressed at low levels in monocyte/macrophages [25,26].
However, mounting evidence reveals the presence of FAK in this cell
lineage [27,28] and unveils its involvement inmacrophagemotility [29].
Todate, studyon the responseofmacrophages toPAMPsvia TLRshas
focusedmainly on the generation of proinﬂammatory cytokines as well
as the release of granular components. Few reports concerning cell
migration are available. Given that Src, a downstream target of nitric
oxide (NO), led to increasedFAKPi-Tyr861 andpromoted cellmotility in
LPS-treatedmacrophages [14],wewonderedwhether the iNOS/Src/FAKFig. 3. PGN, polyI:C, and CpG induced the expression of Src but not its myeloid relatives in m
without or with (A) PGN (5 μg/ml), (B) polyI:C ((I:C)n; 20 μg/ml) and (C) CpG or nCpG (0.3
SDS-PAGE and probed with antibodies as indicated. Similar results were repeated three timaxismight also contribute tomacrophagemobility in response toPAMPs
other than LPS. To answer this question, PGN, polyI:C and CpG known to
activate TLR2, 3, and 9 respectively, were utilized to stimulate
macrophages. We observed that Src was PGN-, polyI:C- and CpG-
inducible and src siRNA inhibitedTLR2-, 3-, or 9-initiatedmotility,which
could be recovered by ectopic avian c-Src. In addition, attenuation of
FAK reduced TLR ligand-induced macrophage movement. Studies
conducted with wild-type (WT) and iNOS knockout (iNOS−/−)
macrophages further supported that iNOS-dependent Src induction
and FAK activation was a general mechanism in macrophage motility
induced by activation of a variety of TLRs.
2. Materials and methods
2.1. Reagents and antibodies
Phosphorothioate backbone-modiﬁed oligodeoxynucleotides (S-
ODN) were purchased from InvivoGen (San Diego, California, USA).
The sequences of the S-ODN used were 5′-TCC ATG ACG TTC CTG ACG
TT-3′ (CpG DNA, ODN1826) and 5′-TCC ATG AGC TTC CTG AGC TT-3′
(nCpG DNA, ODN1826 control). Aminoguanidine hemisulfate (AG),
polyI:C and Staphylococcus aureus PGN were obtained from Sigma (St.
Louis, Missouri, USA). Thioglycollate was obtained from Merck
(Darmstadt, Germany). 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyr-
azolo-[3,4-D]pyrimidine (PP2) was purchased from Calbiochem (La
Jolla, California, USA). The primary antibodies used were actin, iNOS,
FAK (Upstate); FAK Pi-Tyr861 (BIOSOURCE International); Src Pi-
Tyr416 (Cell Signaling Technology); Lyn, Fgr, Hck and HRP-conjugat-
ed anti-phosphotyrosine antibody (PY20) (Santa Cruz Biotechnolo-
gy). The mouse ascites containing monoclonal anti-Src (peptides 2–
17) were produced by the hybridoma (CRL-2651) obtained from the
American Type Culture Collection.
2.2. Animals
Rats (Sprague–Dawley) were utilized to prepare peritoneal
macrophages (PEMs). C57BL/6 inducible nitric oxide synthase
knockout (C57BL/6-Nos™1Lau) (iNOS−/−) and WT mice of the same
age and sex were used to assess the role of iNOS in PGN-, polyI:C-, and
CpG-induced Src expression in macrophages. Mice devoid of iNOS
were normal in appearance, histology, growth rate and reproduction.acrophages. RAW264.7 macrophages (RAW; left) and rat PEMs (right) were stimulated
μg/ml) for 48 h. Equal amounts of lysates (100 μg) from each sample were resolved by
es and the representative was demonstrated.
Fig. 4. Ecotopic Src restored cell migration in PGN-stimulated Src-attenuatedmacrophages. RAW264.7 (RAW) and its derived control cells (Ctrl-1, -2), Src-attenuated cells (siRNA-1, -2),
and Src-attenuated cells harboring a plasmid encoding avian Src (siRNA-1/Src6) were stimulated without or with PGN (5 μg/ml) for 48 h. Equal amounts of lysates (100 μg) from each
samplewere resolved by SDS-PAGE and probedwith antibodies as indicated. Themotility of each groupwas determined asmentioned in Fig. 1. ***pb0.001. Similar results were repeated
three times and the representative was demonstrated.
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All experiments using laboratory animals were done in accordance
with China Medical University guidelines.
2.3. Cell culture
The murine macrophage cell line, RAW264.7 (American Type
Culture Collection), was cultured and propagated in RPMI 1640
medium supplemented with 10% fetal calf serum (HyClone, Logan,
UT) and 2 mM L-glutamine at 37 °C in humidiﬁed atmosphere of 5%
CO2 and air. Peritoneal macrophages (PEMs) were collected by
peritoneal lavage from rats (Sprague–Dawley) or wild-type and
iNOS-null mice given an intraperitoneal injection of 8 ml and 1 ml of
thioglycollate broth, respectively, 4 days before harvest. The PEMs
were washed with Ca+2- and Mg+2-free phosphate-buffered saline
and plated in fetal calf serum-containing RPMI medium overnight.
Then the cells were washed with medium to remove nonadherent
cells. And according to morphological and phagocytic criteria, the
resultant macrophage monolayer was N98% pure and ready for
experimentation. Bonemarrow-derivedmacrophages (BMDMs) were
collected and differentiated as described [31].
2.4. Generation of RAW264.7 macrophages expressing src siRNA
To generate cells expressing src siRNA (siRNA) or the non-speciﬁc
siRNA (Ctrl), RAW264.7 macrophages were transfected with plasmid
DNA pLKO.1-msrc (puro) (targeted sequence: 5′-CGAGCCGCCAA-
TATCCTAGTA-3′; [13]) or the negative control pSilencer plasmid
(which contains sequences not present in mouse genome and
provided by Ambion Inc.) by the Lipofectamine Plus method(Invitrogen) followed by puromycin or hygromycin selection. To
generate Src-attenuated cells expressing ectopic Src, RAW264.7 cells
expressing src siRNAwere cotransfected with pBabe (hygro) DNA and
a plasmid DNA encoding avian c-Src [32] followed by hygromycin
selection.
2.5. Pretreatment with PP2
RAW264.7 cells were cultured with PP2 (10 μM) for 30 min prior
to the addition of PGN, polyI:C, and CpG. These PGN-, polyI:C-, and
CpG-stimulated or non-stimulated cells were then harvested and
their migratory ability was determined.
2.6. Lysate preparation and immunoblot analysis
Lysis of the cells was carried out with modiﬁed radioimmune
precipitation assay buffers as described before [33], and protein
concentration was determined by protein assay kit (Bio-Rad).
Methods for immunoblotting analysis have been described [33]. The
cells lysates were resolved in an 8% SDS-polyacrylamide gel,
transferred to nitrocellulose membranes, and probed with respective
antibodies followed by horseradish peroxidase-conjugated protein A
or horseradish peroxidase-conjugated secondary antibodies and
detected by the Enhanced Chemiluminescence method (Amersham
Biosciences).
2.7. Migration
The migration of macrophages exposed to PGN, polyI:C, or CpG
was determined by using a modiﬁed Boyden chamber as described
Fig. 5. Ecotopic Src restored mobility in polyI:C-exposed Src-attenuated macrophages. RAW264.7 (RAW), Ctrl-1, siRNA-1, siRNA-1/Src6 and siRNA-1/Src15 cells, as described above,
were stimulated without or with polyI:C ((I:C)n, 20 μg/ml) for 48 h. Equal amounts of lysates (100 μg) from each sample were resolved by SDS-PAGE and probed with antibodies as
indicated. The motility of each group was determined as mentioned in Fig. 1. ***pb0.001. Similar results were repeated three times and the representative was demonstrated.
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exposure were added to the upper wells (48-multiwell Boyden
microchambers) at 2×104 cells per well. The migrated cells will
traverse a polycarbonate ﬁlter (8 μm) from the upper chamber to the
lower chamber, which contains 10% fetal calf serum as a chemoat-
tractant. After 5 h at 37 °C in 5% CO2, non-migratory cells on the upper
membrane surface were removed with a cotton swab, and the cells
that traversed and spread on the lower membrane surface were ﬁxed
with methanol and stained with Giemsa stain (Modiﬁed solution,
Sigma). By utilizing a microscope with a 40× objective, the number of
migratory cells per membrane was enumerated. Four random ﬁelds in
each ﬁlter were examined. Each experiment was performed in
triplicate, and migration was expressed as the mean±S.D. of total
cells counted per ﬁeld. In addition, the motility of RAW264.7 and its
derived Ctrl, lyn siRNA-1 and -2, fak siRNA-1 and -2 in response to LPS,
PGN, poly I:C, and CpG was monitored using a Leica AS MDW system
equippedwith a Coolsnap HQ camera (Roper Scientiﬁc). Video images
were collected at intervals of 20 min for 3 h. The positions of nuclei
were tracked to quantify cell motility and analyzed with Metamorph
Software (Universal Imaging Corp.).2.8. RT-PCR
The amount of src and gapdh transcript was semi-quantitated by
RT-PCR as previously described [14].2.9. Statistical analysis
Each experiment was performed at least three times. Unless
indicated, the results were presented as means±S.D. from a
representative triplicate experiment. The signiﬁcance of difference
was assessed by Student's t test. Bonferronic correction was used for
controlling type I error in multiple comparisons.
3. Results
3.1. PGN, polyI:C and CpG enhance cell motility of macrophages
Previously, we have demonstrated that iNOS-dependent Src induc-
tion and FAK activation are involved in TLR4-mediated macrophage
migration [14]. In this study, we were interested to know whether a
similar mechanism could also be applied to TLR2-, TLR3- and TLR9-
elicitedmacrophagemovement. To address this issue, PGN, polyI:C, and
CpG were utilized to individually activate TLR2, TLR3 and TLR9 in
macrophages. And nCpG was used as a negative control for CpG [34].
Compared to non-stimulated and nCpG-stimulated RAW264.7 macro-
phages, signiﬁcantly increased migration was detected in cells treated
with PGN (Fig. 1A, left), polyI:C (Fig. 1B, left) or CpG (Fig. 1C, left). To
conﬁrm that TLR2-, TLR3- and TLR9-evoked macrophage mobilizations
are a physiological event, thioglycollate-elicited rat PEMs were
harvested and their migratory potential in response to these agonists
was assessed. Indeed, PEMs exposed to PGN (Fig. 1A, right), polyI:C
Fig. 6. Ecotopic Src restored motility in CpG-stimulated Src-attenuated macrophages. RAW264.7-derived control Ctrl, siRNA-1, siRNA-1/Src6 and siRNA-1/Src15 cells were
stimulated without or with CpG or nCpG (0.3 μg/ml) for 48 h. Equal amounts of lysates (100 μg) from each sample were resolved by SDS-PAGE and probed with antibodies as
indicated. The motility of each group was determined as mentioned in Fig. 1. ***pb0.001. Similar results were repeated three times and the representative was demonstrated.
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potential as compared to thosewithout treatment or treatedwith nCpG.
Similar results were observed in BMDMs stimulated with LPS and the
other three TLR agonists (Fig. 2). Intriguingly, this PGN- (Fig. 1A, left),
polyI:C- (Fig. 1B, left), or CpG-elicitedmacrophagemotility (Fig. 1C, left)
was sensitive to PP2 (an SFK inhibitor), implicating the role of SFKs in
this process.
3.2. PGN, polyI:C, and CpG induce Src expression in macrophages
To pinpoint the SFK(s) responsible for PGN-, polyI:C-, and CpG-
triggered migration, the expression of Src and its myeloid relatives
(i.e. Lyn, Fgr and Hck) in RAW264.7 cells without or with stimulation
of each ligand was examined. While the expression of the myeloid
SFKs was almost unaltered, signiﬁcant Src induction was observed in
RAW264.7 cells exposed to PGN (Fig. 3A), polyI:C (Fig. 3B) or CpG
(Fig. 3C). To exclude the possibility that PGN-, polyI:C-, and CpG-
elevated Src expression was an in vitro artifact that only occurred in
RAW264.7, PEMs and BMDMs were utilized to answer this question.
As shown in Fig. 3, while the expression of Lyn, Fgr, and Hck was
unchanged, Src induction was detected in PEMs after a 48-h exposure
of PGN, polyI:C, and CpG. Similar ﬁndings were also obtained in
BMDMs (Fig. 2). These results conﬁrmed that PGN-, polyI:C-, and CpG-
mediated Src enhancement was a bona-ﬁde physiological event
occurred in macrophages.
3.3. Src-mediated FAK Pi-Tyr861 in PGN-, polyI:C-, and CpG-stimulated
macrophages
Following exposure to various TLR ligands, the simultaneous
increase of Src expression and macrophage migration suggested theimportance of Src in this process. To prove this, non-speciﬁc and src-
speciﬁc siRNA-bearing plasmids were introduced into RAW264.7
macrophages to obtain the corresponding control (Ctrl-1 and -2) and
siRNA (siRNA-1 and -2) cells, respectively. Signiﬁcant Src induction
was observed in parental and control cells, but not in src siRNA-
expressing RAW264.7 cells following stimulation with PGN (Fig. 4),
polyI:C (Fig. 5), or CpG (Fig. 6). Notably, like parental and control cells,
the expression of Lyn was almost unaltered in Src-attenuated cells in
the presence or absence of PGN (Fig. 4), polyI:C (Fig. 5), and CpG
(Fig. 6). Analysis of cell motility by transwell assay revealed that PGN-,
polyI:C-, and CpG-induced cell mobility was signiﬁcantly suppressed
in Src-attenuated RAW264.7. To verify these results, we further
generated Src-attenuated cells expressing avian Src (siRNA-1/Src6,
siRNA-1/Src15) [14] and demonstrated that reduced PGN-, polyI:C-,
and CpG-elicited macrophage mobilization could be restored by
ectopic Src (Figs. 4, 5 and 6). Since FAK is a substrate of Src and
regulates macrophagemotility [29], therefore, its activity (as reﬂected
by FAK Pi-Tyr861) in these cells treated with PGN, polyI:C, or CpGwas
examined. Markedly, PGN (Fig. 4), polyI:C (Fig. 5), or CpG (Fig. 6)
increased FAK Pi-Tyr861 in RAW264.7, which was greatly suppressed
by Src deprivation and was restored by Src reintroduction.
3.4. Attenuation of Lyn does not suppress LPS-, PGN-, polyI:C-, and
CpG-mediated macrophage migration
Given the almost unaltered expression of myeloid SFKs in macro-
phages exposed to various TLR ligands, their involvement in mobility
was attempted. Among the three Src relatives, we chose Lyn to address
this issue. Nonspeciﬁc and two different lyn-speciﬁc siRNA-bearing
plasmids were introduced into RAW264.7 macrophages to obtain the
corresponding control (Ctrl) and siRNA (lyn siRNA-1 and -2) cells,
Fig. 7. Attenuation of Lyn does not impair LPS-, PGN-, polyI:C-, and CpG-induced macrophage migration. (A) The generation of Lyn-attenuated RAW264.7 (RAW) cells were
performed exactly as the generation of Src knockdown cells except that plasmid DNA pLKO.1-mlyn-1 (puro) (targeted sequence: 5′-CGCGAGAGTCATCGAAGATAA-3′) and plasmid
DNA pLKO.1-mlyn-2 (puro) (targeted sequence: 5′-GCCAAGGTCAACACCTTAGAA-3′) were transfected to generate lyn siRNA-1 cells and lyn siRNA-2 cells, respectively. RAW264.7
and its derived control cells (Ctrl) and Lyn-attenuated cells (lyn siRNA-1 and -2) were stimulated without or with either LPS (100 ng/ml) or PGN (5 μg/ml) for 48 h. Equal amounts of
lysates (100 μg) from each sample were resolved by SDS-PAGE and probed with antibodies as indicated. (B) RAW264.7 and its derived cells as described above were stimulated
without or with LPS, PGN, polyI:C, and CpG for 48 h. Movement of these cells were monitored by time-lapse video microscopy and tracked for 20-min intervals over a span of 3 h.
Motility was calculated as velocity (μm/3 h) using image processing software as described under “Materials and methods.” Data from these ﬁelds of cells (N20 cells/ﬁeld) were
collected and calculated in each cell line, and the results were means±S.D. of a representative experiment.
142 M.-C. Maa et al. / Biochimica et Biophysica Acta 1813 (2011) 136–147respectively. Despite that the expression of Lyn was reduced in siRNA
cells, still like parental and Ctrl cells, their Src expression was greatly
augmented in response to LPS, PGN, polyI:C, and CpG (Fig. 7A and data
not shown). Increased motility was also observed in Lyn-attenuated
macrophages exposed to all these ligands (Fig. 7B). These ﬁndings
suggested that Lyn did not contribute to TLR-mediated macrophage
movement.3.5. Attenuation of FAK reduces LPS-, PGN-, polyI:C-, and CpG-induced
macrophage migration
To ascertain that FAK is critical in macrophage mobilization, non-
speciﬁc and two different fak-speciﬁc siRNA-bearing plasmids were
introduced into RAW264.7 to obtain the corresponding control (Ctrl)
and siRNA (fak siRNA-1 and -2) cells, respectively. As shown in Fig. 8,
attenuation of FAK impaired macrophage mobility in response to LPS,
PGN, polyI:C, and CpG. These results conﬁrmed that Src/FAK axis
played a pivotal role in various TLR ligand-elicited macrophage
mobilization.3.6. iNOS is required for PGN-, polyI:C-, and CpG-induced macrophage
motility
Given that iNOS participated in LPS-mediated macrophage migra-
tion [14], therefore, we analyzed the migratory potential of PGN-,
polyI:C- and CpG-treated PEMs derived from WT and iNOS−/− mice.
Compared to WT PEMs, reduced migration evoked by PGN (Fig. 9A),
polyI:C (Fig. 9B), and CpG (Fig. 9C) was observed in iNOS-null PEMs.
These data indicated the involvement of iNOS in macrophage
movement initiated by these TLR ligands.
3.7. PGN-, polyI:C- and CpG-elicited Src induction and FAK activation is
iNOS-dependent
Bymodulating Src/FAK pathway, iNOS is involved in LPS-mediated
macrophage mobility [14]. To study whether a similar mechanism can
also be utilized by macrophages exposed to PGN, polyI:C, or CpG, cell
lysates prepared fromWT and iNOS−/− PEMs treated without or with
the respective ligand were collected and analyzed. Western blot
analysis revealed that concurrent with the absence of iNOS,
Fig. 8. FAK knockdown decreases LPS-, PGN-, polyI:C-, and CpG-induced macrophage migration. (A) Plasmid DNA pLKO.1-mfak-1 (puro) (targeted sequence: 5′-GCCTTAACAATGCGT-
CAGTTT-3′) and pLKO.1-mfak-2 (puro) (targeted sequence: 5′-CCTGGCATCTTTGATATTATA-3′) were used to generate fak siRNA-1 and fak siRNA-2 (FAK-attenuated cells), respectively.
RAW264.7 (RAW)and its derived control cells (Ctrl) and FAK-attenuated cells (fak siRNA-1and -2)were stimulatedwithoutorwith either LPS (100 ng/ml)orPGN(5 μg/ml) for 48 h. Equal
amounts of lysates (100 μg) fromeach samplewere resolved bySDS-PAGE and probedwith antibodies as indicated. (B)RAW264.7 and its derived cells as described abovewere stimulated
without or with LPS, PGN, polyI:C, and CpG for 48 h. The motility of these cells was measured exactly as described in Fig. 7. ***pb0.001. The results were means±S.D. of a representative
experiment.
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relatives) was detected in PGN- (Fig. 10, left), polyI:C- (Fig. 10,
middle), and CpG- (Fig. 10, right) stimulated iNOS−/− PEMs. Besides,
iNOS deﬁciency not only suppressed Src activation (as reﬂected by Src
Pi-Tyr416), but also ablated PGN-, polyI:C-, and CpG-elicited FAK Pi-
Tyr861 (Fig. 10). Consistently, aminoguanidine hemisulfate (AG, an
iNOS inhibitor) treatment led to the decrement of protein and RNA
transcript of Src evoked by TLR ligands (Fig. 11). These results
unveiled that by virtue of Src induction and FAK activation, iNOS was
crucial in PGN-, polyI:C-, and CpG-induced macrophage locomotion.
4. Discussion
Src was important in LPS-mediated macrophage motility [14]. To
investigate whether Src was also critical in macrophage movement in
response to other PAMPs, PGN, polyI:C, and CpG were chosen to treat
macrophages in this study. Here, we observed that PGN, polyI:C, and
CpG increased cell migration in RAW264.7 cells, PEMs (Fig. 1), and
BMDMs (Fig. 2). The greatly reduced motility by PP2 implicated the
involvement of SFKs in PGN-, polyI:C-, and CpG-triggered movement.
Like LPS treatment, the inducible characteristic of Src could be detected
in RAW264.7, PEMs (Fig. 3), and BMDMs (Fig. 2) exposed to these TLR
agonists. Notably, Src attenuation led to reduced PGN- (Fig. 4), polyI:C-
(Fig. 5), and CpG- (Fig. 6) evokedmotility in RAW264.7, and ectopically
expressed avian Src rescued this defect (Figs. 4, 5 and 6). These ﬁndingssubstantiated that Src was involved in macrophage mobilization
induced by PGN, polyI:C, and CpG.
For a long period of time, FAKwas thought to regulate focal adhesion
turnover and mobility in ﬁbroblasts [17,18,35]. Its involvement in
macrophagemigrationwas vague. Recently, Owen et al. have generated
myeloid-speciﬁc conditional FAKknockoutmice and demonstrated that
PEMs derived from these mice displayed signiﬁcant migration defects,
which was coincident with suppressed adhesion turnover and forma-
tion of stable lamellipodia necessary for directional locomotion [29].
Meanwhile, FAK deﬁciency also led to decreased inﬁltration of
monocytes into sites of inﬂammation in vivo. Intriguingly, sustained
FAK activation that perturbed cytoskeletal disassembly was reported to
be responsible for oxidized LDL-induced macrophage trapping in
atheroinﬂammatory lesions [36]. As the role of FAK in macrophage
mobilization was fully disclosed, we demonstrated that Src could
mediate FAKPi-Tyr861, an indicator of FAK activation [24], to contribute
to enhanced movement in PGN-, polyI:C-, and CpG-treated RAW264.7
(Figs. 4, 5, and 6). In agreementwith this notion, reducedmigrationwas
detected in FAK-attenuated RAW264.7 exposed to various TLR ligands
(Fig. 8).
Due to its low basal expression in macrophages, the physiological
signiﬁcance of Src is concealed and underestimated. In contrast, the
three myeloid Src relatives (i.e. Fgr, Hck, and Lyn) with high protein
expression are spotlighted. As the expressionof Srcwas inducible by LPS
[14,37] aswell as other TLR ligands (Figs. 2 and 3), Src was conﬁrmed to
Fig. 9. iNOS is required for PGN-, polyI:C- and CpG-inducedmacrophagemigration. PEMs fromwild type (WT) and iNOS−/−micewere stimulatedwithout orwith (A) PGN (5 μg/ml),
(B) polyI:C ((I:C)n, 20 μg/ml), and (C) nCpG or CpG (0.3 μg/ml) for 48 h. Then, the motility of PEMs (2×104 cells) harvested from each group was determined by a modiﬁed Boyden
chamber as described under “Materials and methods.” ***, pb0.001. Similar results were repeated three times and the representative was demonstrated.
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TLRs. However, the role of myeloid SFKs in this process was unclear.
Here, with Lyn-attenuated RAW264.7, we presented evidence to
exclude its participation in macrophage migration elicited by various
TLR ligands (Fig. 7).
Amigration-stimulatory role of NOhas been reported in diverse cell
types. For instance, migratory potential of primary aortic smooth
muscle cells was augmented by NO [38]. Also, NO was critical for a
switch from stationary to locomoting phenotype in epithelial cells [39].
Furthermore, NO played a permissive role in endothelial cell migration
induced by substance P [40], endothelin [41], and vascular endothelial
growth factor [42]. Recently, we reported that LPS-mediated Src
induction led to increased FAK activation and cell migration in
macrophages, and which was iNOS-dependent [14]. Herein, studies
conducted with WT and iNOS−/− macrophages provided further
deﬁnitive evidence regarding the role of iNOS in the concomitant
induction of Src, activation of FAK (Fig. 10) and cell movement (Fig. 9)
in macrophages exposed to PGN, polyI:C, and CpG. Of note, iNOS
inhibitor treatment led to the decrement of protein and RNA transcript
of src induced by TLR ligands (Fig. 11). It is well established that soluble
guanylyl cyclase (sGC) is a main target of NO, and activation of sGC can
convertGTP to cGMP, an intracellular secondmessenger. Given (1) LPS-
mediated Src induction could be impaired byODQ (an inhibitor of sGC),
(2) 8-bromo-cGMP (8-Br-cGMP, a cGMP analogue) could induce Srcexpression, and (3) the expression of Src in iNOS-null PEMs could be
restored by SNAP (aNOdonor) and8-Br-cGMP to a level comparable to
that detected in normal PEMs [14], we concluded that NO/cGMP
pathway could contribute to Src induction by TLR ligands.
Due to residual Src expression and activity were still detected in
iNOS-null macrophages exposed to various TLR ligands (Fig. 10),
therefore iNOS/NOshould not be the only signalingpathway leading to
Src induction. Besides, in addition to SFKs, PP2 was also reported to
inhibit other protein kinases including Abl [43] involved in LPS-
mediated macrophage activation [44]. Because PP2 exerted more
inhibitory effect than iNOS absence did, thereby, in addition to Src,
other PP2-sensitive tyrosine kinase(s) might also be involved in
TLR-mediated cell motility.
In contrast to the large repertoire of rearranged receptors utilized
by the acquired system, the innate immunity recognizes microorgan-
isms via a limited number of germline-encoded pattern-recognition
receptors including TLRs [4]. Irrespective of their localization and
utilization of different TIR-containing adaptors, engagement of TLRs
led to activation of NF-κB and augmented expression of iNOS, COX-2,
and proinﬂammatory cytokines [6]. As PGN, polyI:C, and CpG were
used as stimulants in this study, we actually analyzed TLRs located on
plasma membrane (i.e. TLR2) vs. endosome (i.e. TLR3 and 9). Besides,
the signaling pathways of the TLRs studied could be divided into
MyD88-dependent (i.e. TLR2 and 9) and -independent (i.e. TLR3).
Fig. 10. iNOS was required for PGN-, polyI:C-, and CpG-evoked Src expression and FAK activation. PEMs fromwild type (WT) and iNOS−/−mice were stimulatedwithout or with PGN
(5 μg/ml) (left), polyI:C ((I:C)n, 20 μg/ml) (middle), and nCpG or CpG (0.3 μg/ml) (right) for 48 h. Equal amounts of their lysates (30 μg) were resolved by SDS-PAGE and probed
with antibodies as indicated. Asterisks marked the position of Src Pi-Tyr416. Similar results were repeated three times and the representative was demonstrated.
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led to Src upregulation and FAK activation that were iNOS-dependent.
Given that Src increased the activity of NF-κB [45,46], thereby a loop of
signal ampliﬁcation can be established. With what we have learned
from studies conducted in RAW264.7 macrophages as well as normal
vs. iNOS−/− PEMs, a simple model illustrating the responsible
mechanism for TLR ligand-triggered, iNOS-dependent macrophage
migration was proposed in Fig. 12. Given that mobilization of
activated macrophages from the infection area to the regional
lymph node where they present antigens to naïve CD4+ T cells is an
indispensable step in activating the adaptive immunity [4], we
speculate that the iNOS→Src→FAK signaling pathway observed in
this report is likely to be a general mechanism utilized by TLR-
engaged macrophages critical in host defenses.
In conclusion, we demonstrate that PGN, polyI:C, and CpG can
elicit macrophage migration via their respective TLR and iNOS. Src is
a critical player herein since its upregulation and activation
mediated by NO results in augmented FAK activity and cell
migration. Considering that the accumulation of macrophagesFig. 11. iNOS inhibitor reduces both protein and RNA transcript of src in macrophages
exposed to PGN, polyI:C, and CpG. RAW264.7 cells were pretreated without or with AG
(2 mM) for 30 min, and then stimulated with PGN, polyI:C, and CpG for 48 h. Equal
amounts of lysates from each sample were resolved by SDS-PAGE and probed with
antibodies as indicated (upper panel). The amount of src transcript was analyzed by RT-
PCR. gapdh was utilized as an internal control for ampliﬁcation efﬁciency (bottom
panel).contributes to the progression of diseases such as cancer and
chronic inﬂammatory diseases, our data highlight the potential of
iNOS, Src, and FAK to be therapeutic targets. By suppressing their
activity, we might control infection, inﬂammation, and the mainte-
nance of tissue homeostasis.
Acknowledgements
This study is supported in part by Taiwan Department of Health
Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004
to M.-C. M.), Taiwan Department of Health Cancer Research Center of
Excellence (DOH99-TD-C-111-005 to M.-C. M.) and in part by grants
from National Science Council (NSC98-2311-B-039-002-MY3 to
M.-C.M), National Health Research Institute (NHRI-EX98-9828BI to
T.-H.L.), and China Medical University (CMU97-CMC-011 to M.-C.M.).
The DNA constructs of pLKO.1-mfak-1, pLKO.1-mfak-2, pLKO.1-mlyn-1,
and pLKO.1-mlyn-2 were provided by the National RNAi Core Facility
located at the Institute of Molecular Biology/Genomic Research Center,
Academia Sinica, supported by the National Research Program for
Genomic Medicine Grants of NSC (NSC 94-3112-B-001-003 and NSC
94-3112-B-001-018-Y).References
[1] O. Takeuchi, S. Akira, Pattern recognition receptors and inﬂammation, Cell 140
(2010) 805–820.
[2] A.M. Keestra, M.R. de Zoete, R.A. van Aubel, J.P. van Putten, The central leucine-rich
repeat regionof chicken TLR16dictates unique ligand speciﬁcity and species-speciﬁc
interaction with TLR2, J. Immunol. 178 (2007) 7110–7119.
[3] T. Kawai, S. Akira, Signaling to NF-kB by Toll-like receptors, Trends Mol. Med. 13
(2007) 460–469.
[4] S. Akira, S. Uematsu, O. Takeuchi, Pathogen recognition and innate immunity, Cell
124 (2006) 783–801.
[5] S. Akira, S. Sato, Toll-like receptors and their signaling mechanisms, Scand. J.
Infect. Dis. 35 (2003) 555–562.
[6] E. Kopp, R. Medzhitov, Recognition of microbial infection by Toll-like receptors,
Curr. Poin. Immunol. 15 (2003) 396–401.
[7] M.S. Jin, J.O. Lee, Structures of the Toll-Like receptor family and its ligand
complexes, Immunity 29 (2008) 182–191.
[8] A.M. Krieg, Development of TLR9 agonists for cancer therapy, J. Clin. Invest. 117
(2007) 1184–1194.
[9] B.A. Beutler, TLRs and innate immunity, Blood 113 (2009) 1399–1407.
[10] R. Ishizawar, S.J. Parsons, c-Src and cooperating partners in human cancer, Cancer
Cell 6 (2004) 209–214.
Fig. 12. Signal transduction pathways of diverse TLR-mediated macrophage migration. As LPS activates TLR4, PGN, polyI:C and CpG triggers the activation of TLR2, 3 and 9,
respectively, which induces the expression of iNOS via activation of NF-κB. NO, the second messenger generated by iNOS, upregulates the expression and activity of Src, leading to
FAK activation (as reﬂected by its Pi-Tyr861) and cell movement. Notably, Src increases the activity of NF-κB, thus a loop of signal ampliﬁcation for macrophage movement can be
constructed. This model highlights a general mechanism utilized in macrophages when their TLRs are engaged.
146 M.-C. Maa et al. / Biochimica et Biophysica Acta 1813 (2011) 136–147[11] F. Meng, C.A. Lowell, Lipopolysaccharide (LPS)-induced macrophage activation
and signal transduction in the absence of Src-family kinases Hck, Fgr and Lyn, J.
Exp. Med. 185 (1997) 1661–1670.
[12] C.A. Lowell, Src-family kinases: rheostats of immune cell signaling, Mol. Immunol.
41 (2004) 631–643.
[13] T.H. Leu, S. Charoenfuprasert, C.K. Yen, C.W. Fan,M.C.Maa, Lipopolysaccharide-induced
c-Src expression plays a role in nitric oxide and TNFα secretion in macrophages, Mol.
Immunol. 43 (2006) 308–316.
[14] M.C.Maa,M.Y. Chang, Y.J. Chen, C.H. Lin, C.J. Yu, Y.L. Yang, J. Li, P.R. Chen,C.H. Tang, H.Y.
Lei, T.H. Leu, Requirement of inducible nitric oxide synthase in lipopolysaccharide-
mediated Src induction and macrophage migration, J. Biol. Chem. 283 (2008)
31408–31416.
[15] S.K. Hanks, M.B. Calalb, M.C. Harper, S.K. Patel, Focal adhesion protein-tyrosine
kinase phosphorylated in response to cell attachment to ﬁbronectin, Proc. Natl
Acad. Sci. USA 89 (1992) 8487–8491.
[16] M.D. Schaller, C.A. Borgman, J.T. Parsons, Autonomous expression of a noncatalytic
domain of the focal adhesion-associated protein tyrosine kinase pp 125FAK, Mol.
Cell. Biol. 13 (1993) 785–791.
[17] J.T. Parsons, Focal adhesion kinase: the ﬁrst ten years, J. Cell Sci. 116 (2003)
1409–1416.
[18] S.K. Hanks, L. Ryzhova, N.Y. Shin, J. Brabek, Focal adhesion kinase signaling
activities and their implications in the control of cell survival and motility, Front.
Biosci. 8 (2003) d982–d996.
[19] D. Ilic, Y. Furuta, S. Kanazawa, N. Taketa, K. Sobue, N. Nakatsuji, S. Ninomira, J.
Fujimoto, M. Okada, T. Yamamoto, Reduced cell motility and enhanced focal
adhesion contact formation in cells from FAK-deﬁcient mice, Nature 377 (1995)
539–544.
[20] D.J. Sieg, D. Ilic, K.C. Jones, H.C. Damsky, T. Hunter, D.D. Schlaepfer, Pyk2 andSrc-family
protein-tyrosine kinases compensate for the loss of FAK in ﬁbronectin-stimulated
signalingevents butPyk2doesnot fully function to enhanceFAK-cellmigration,EMBO
J. 7 (1998) 5933–5947.
[21] D.J. Sieg, C.R. Hauck, D.D. Schlaepfer, Required role of focal adhesion kinase (FAK)
for integrin-stimulated cell migration, J. Cell Sci. 112 (1999) 2677–2691.
[22] M.B. Calalb, T.R. Polte, S.K. Hanks, Tyrosine phosphorylation of focal adhesion
kinase at sites in the catalytic domain regulates kinase activity: a role for Src
family kinases, Mol. Cell. Biol. 15 (1995) 954–963.
[23] M.B. Calalb, X. Zhang, T.R. Polte, S.K. Hanks, Focal adhesion kinase Tyrosine-861 is
a major site of phosphorylation by Src, Biochem. Biophys. Res. Commun. 228
(1996) 662–668.
[24] T.H. Leu, M.C. Maa, Tyr-863 phosphorylation enhances focal adhesion kinase
autophosphorylation at Tyr-397, Oncogene 21 (2002) 6992–7000.
[25] T.H. Lin, A. Yurochko, L. Kornberg, J. Morris, J.J. Walker, S. Haskill, R.L. Juliano, The
role of protein tyrosine phosphorylation in integrin-mediated gene induction in
monocytes, J. Cell Biol. 126 (1994) 1585–1593.
[26] M.O. De Nichilo, K.M. Yamada, Integrin alpha v beta 5-dependent serine
phosphorylation of paxillin in cultured human macrophages adherent to
vitronectin, J. Biol. Chem. 271 (1996) 11016–11022.
[27] M. Okigaki, C. Davis, M. Falasca, S. Harroch, D.P. Felsenfeld, M.P. Sheetz, J.
Schlessinger, Pyk2 regulates multiple signaling events crucial for macrophagemorphology and migration, Proc. Natl Acad. Sci. USA 100 (2003)
10740–10745.
[28] E. Rovida, B. Lugli, V. Barbetti, S. Giuntoli, M. Olivotto, P. Dello Sbarba, Focal
adhesion kinase is redistributed to focal complexes andmediates cell spreading in
macrophages in response to M-CSF, Biol. Chem. 386 (2005) 919–929.
[29] K.A. Owen, F. Pixley, K.S. Thomas, M. Vicente-Manzanares, B. Ray, A.F. Horwitz, J.T.
Parsons, H.E. Beggs, E.R. Stanley, A.H. Bouton, Regulation of lamellipodial
persistence, adhesion turnover, and motility in macrophages by focal adhesion
kinase, J. Cell Biol. 179 (2007) 1275–1287.
[30] V.E. Laubach, E.G. Shesely, O. Smithies, P. Sherman, Mice lacking inducible nitric
oxide synthase are not resistant to lipopolysaccharide-induced death, Proc. Natl
Acad. Sci. USA 92 (1995) 10688–10692.
[31] S. Shi, C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T.R.
Gingeras, G. Schoolnik, S. Akira, K. Takeda, S. Ehrt, MyD88 primes macrophages for
full-scale activation by interferon-γ yet mediates few responses toMycobacterium
tuberculosis, J. Exp. Med. 198 (2003) 987–997.
[32] L.K. Wilson, D.K. Luttrell, J.T. Parsons, S.J. Parsons, pp 60c-src tyrosine kinase,
myristylation, and modulatory domains are required for enhanced mitogenic
responsiveness to epidermal growth factor seen in cells overexpressing c-src, Mol.
Cell. Biol. 9 (1989) 1536–1544.
[33] M.C. Maa, T.H. Leu, Vanadate-dependent FAK activation is accomplished by the
sustained FAK Tyr-576/577 phosphorylation, Biochem. Biophys. Res. Commun.
251 (1998) 344–349.
[34] K.K. Baek, S.J. Ha, Y.C. Sung, A novel function of phosphorothioate oligodeox-
ynucleotides as chemoattractants for primary macrophages, J. Immunol. 167
(2001) 2847–2854.
[35] D.D. Schlaepfer, S.K. Mitra, D. Ilic, Control of motile and invasive cell phenotypes
by focal adhesion kinase, Biochim. Biophys. Acta 1692 (2004) 77–102.
[36] Y.M. Park, M. Febbraio, R.L. Silverstein, CD36 modulates migration of mouse and
human macrophages in response to oxidized LDL and may contribute to
macrophage trapping in the arterial intima, J. Clin. Invest. 119 (2009) 136–145.
[37] Y. Abu-Amer, F.P. Ross, J. Edwards, S.L. Teitelbaum, Lipopolysaccharide-stimulated
osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor, J.
Clin. Invest. 100 (1997) 1557–1565.
[38] C. Brown, X. Pan, A. Hassid, Nitric oxide and C-type atrial natriuretic peptide
stimulate primary aortic smooth muscle cell migration via a cGMP-dependent
mechanism-relationship tomicroﬁlament dissociation and altered cell morphology,
Circ. Res. 84 (1999) 655–667.
[39] E. Noiri, T. Peresleni, N. Srivastava, P. Weber, W.F. Bahou, N. Peunova, M.S.
Goligorsky, Nitric oxide is necessary for a switch from stationary to locomoting
phenotype in epithelial cells, Am. J. Physiol. 270 (1996) C794–C802.
[40] M. Ziche, L. Morbidelli, C. Masini, S. Amerini, H. Granger, C. Maggi, P. Geppetti, F.
Ledda, Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and
migration in vitro promoted by substance P, J. Clin. Invest. 94 (1994) 2036–2044.
[41] E. Noiri, Y. Hu, W.F. Bahou, C.R. Keese, I. Giaever, M.S. Goligorsky, Permissive role
of nitric oxide in endothelin-induced migration of endothelial cells, J. Biol. Chem.
272 (1997) 1747–1752.
[42] M. Ziche, L. Morbidelli, R. Choudhuri, H.T. Zhang, S. Donnini, H.J. Granger, R.
Bicknell, Nitric oxide synthase lies downstream from vascular endothelial growth
147M.-C. Maa et al. / Biochimica et Biophysica Acta 1813 (2011) 136–147factor-induced but not ﬁbroblast growth factor-induced angiogenesis, J. Clin.
Invest. 99 (1997) 2625–2634.
[43] L. Tatton, G.M. Morley, R. Chopra, A. Khwaja, The Src selective kinase inhibitor PP1
also inhibits kit and Bcr-Abl tyrosine kinases, J. Biol. Chem. 278 (2003) 4847–4853.
[44] Q. Le, R. Daniel, S.W. Chung, A.D. Kang, T.K. Eisenstein, B.M. Sultzer, H. Simpkins, P.M.
Wong, Involvement of C-Abl tyrosine kinase in lipopolysaccharide-induced
macrophage activation, J. Immunol. 160 (1998) 3330–3336.[45] Y. Abu-Amer, F.P. Ross, K.P. Mchugh, A. Livolsi, J.-F. Peyron, S.L. Teitelbaum, Tumor
necrosis factor-α activation of nuclear transcription factor-κB in marrow
macrophages is mediated by c-Src tyrosine phosphorylation of IκBα, J. Biol.
Chem. 273 (1998) 29417–29423.
[46] W.C. Hung, J.J. Chen, C.C. Chen, c-Src-dependent tyrosine phosphorylation of IKKβ
is involved in tumor necrosis factor-α-induced intercellular adhesion molecule-1
expression, J. Biol. Chem. 278 (2003) 9944–9952.
